Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1985 1
1986 2
1987 1
1988 1
1989 1
1990 1
1993 1
2014 1
2015 1
2020 1
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Results by year

Filters applied: . Clear all
Page 1
Fecal microbiome alterations in treatment-naive de novo Parkinson's disease.
Boertien JM, Murtomäki K, Pereira PAB, van der Zee S, Mertsalmi TH, Levo R, Nojonen T, Mäkinen E, Jaakkola E, Laine P, Paulin L, Pekkonen E, Kaasinen V, Auvinen P, Scheperjans F, van Laar T; PPNN Study Group. Boertien JM, et al. NPJ Parkinsons Dis. 2022 Oct 10;8(1):129. doi: 10.1038/s41531-022-00395-8. NPJ Parkinsons Dis. 2022. PMID: 36216843 Free PMC article.
Cranio-vertebral pathology in Down syndrome.
Braakhekke JP, Gabreëls FJ, Renier WO, van Rens TJ, Thijssen HO, Begeer JH. Braakhekke JP, et al. Clin Neurol Neurosurg. 1985;87(3):173-9. doi: 10.1016/0303-8467(85)90003-4. Clin Neurol Neurosurg. 1985. PMID: 2932274
The second wind phenomenon in McArdle's disease.
Braakhekke JP, de Bruin MI, Stegeman DF, Wevers RA, Binkhorst RA, Joosten EM. Braakhekke JP, et al. Brain. 1986 Dec;109 ( Pt 6):1087-101. doi: 10.1093/brain/109.6.1087. Brain. 1986. PMID: 3466659
Study protocol of the DUtch PARkinson Cohort (DUPARC): a prospective, observational study of de novo Parkinson's disease patients for the identification and validation of biomarkers for Parkinson's disease subtypes, progression and pathophysiology.
Boertien JM, van der Zee S, Chrysou A, Gerritsen MJJ, Jansonius NM, Spikman JM, van Laar T; PPNN Study Group. Boertien JM, et al. BMC Neurol. 2020 Jun 13;20(1):245. doi: 10.1186/s12883-020-01811-3. BMC Neurol. 2020. PMID: 32534583 Free PMC article.
11 results